CH5137291 - CAS 1043446-39-4
Catalog number: 1043446-39-4
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C18H14F3N5O3S2
Molecular Weight:
469.46
COA:
Inquire
Targets:
Androgen Receptor
Description:
CH5137291 is a potent androgen receptor (AR) pure antagonist which did not produce the agonist metabolite with AR nuclear translocation-inhibiting activity. It inhibits the growth of castration-resistant prostate cancer cells. It offers a novel therapeutic approach against major types of castration-resistant prostate cancers.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98 %
Appearance:
Solid powder
Synonyms:
CH-5137291;6-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)pyridine-2-sulfonamide
Solubility:
10 mM in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
CH5137291 offers a novel therapeutic approach against major types of castration-resistant prostate cancers.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
Boiling Point:
654.4±65.0 °C | Condition: Press: 760 Torr
Density:
1.65±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
JIIHFLNYGVNTFP-UHFFFAOYSA-N
InChI:
InChI=1S/C18H14F3N5O3S2/c1-17(2)15(27)25(11-7-6-10(9-22)12(8-11)18(19,20)21)16(30)26(17)13-4-3-5-14(24-13)31(23,28)29/h3-8H,1-2H3,(H2,23,28,29)
Canonical SMILES:
CC1(C(=O)N(C(=S)N1C2=NC(=CC=C2)S(=O)(=O)N)C3=CC(=C(C=C3)C#N)C(F)(F)F)C
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Androgen Receptor Products


CAS 956104-40-8 Apalutamide

Apalutamide
(CAS: 956104-40-8)

ARN-509, also known as JNJ-56021927, is an androgen receptor antagonist with potential antineoplastic activity. ARN-509 binds to AR in target tissues thereby p...

CAS 90357-06-5 Bicalutamide

Bicalutamide
(CAS: 90357-06-5)

Bicalutamide is a non-steroidal androgen receptor (AR) antagonist with IC50 of 0.16 μM.

CAS 34633-34-6 BX341

BX341
(CAS: 34633-34-6)

BX341, also known as bifluranol, is a new fluorinated bibenzyl anti-androgen and one of a series of bibenzyls designed to present some of the hormonal propertie...

MK-3984
(CAS: 871325-55-2)

MK-3984 is a androgen receptor modulators. It can be used for the prevention and treatment of muscle wasting associated with cancer.

CAS 52-01-7 Spironolactone

Spironolactone
(CAS: 52-01-7)

Spironolactone is a potent antagonist of the androgen receptor with IC50 of 77 nM.

CAS 1182367-47-0 RAD140

RAD140
(CAS: 1182367-47-0)

RAD140, an effective non-steroidal selective androgen receptor modulator, could probably stimulate the increasing of muscle and also has been found to have pote...

CAS 154992-24-2 RU 58841

RU 58841
(CAS: 154992-24-2)

RU 58841 is a new non-steroidal antiandrogen which has potential for use in treating androgen-dependent skin disorders such as acne, hirsutism and androgen-depe...

CAS 643094-49-9 Fasobegron

Fasobegron
(CAS: 643094-49-9)

Fasobegron acts a β3-adrenoreceptor agonist.

CAS 401900-40-1 Andarine

Andarine
(CAS: 401900-40-1)

Andarine is a selective non-steroidal androgen receptor (AR) agonist with Ki of 4 nM, tissue-selective for anabolic organs.

CAS 915087-33-1 Enzalutamide

Enzalutamide
(CAS: 915087-33-1)

Enzalutamide is an androgen-receptor (AR) antagonist with IC50 of 36 nM. It inhibits the activity of prostate cancer cell Ars, which over expressed in prostate ...

CAS 60607-35-4 Topterone

Topterone
(CAS: 60607-35-4)

A steroidal antiandrogen drug

CH5137291
(CAS: 1043446-39-4)

CH5137291 is a potent androgen receptor (AR) pure antagonist which did not produce the agonist metabolite with AR nuclear translocation-inhibiting activity. It ...

ASC-J9
(CAS: 52328-98-0)

ASC-J9 is an AR degradation enhancer, suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen rece...

CAS 1240299-33-5 AZD-3514

AZD-3514
(CAS: 1240299-33-5)

AZD-3514 is a potent androgen receptor downregulator with potential anticancer cancer activity. AZD3514 is being evaluated in a Phase I clinical trial in patie...

JNJ-26146900
(CAS: 868691-50-3)

JNJ-26146900 is a selective, nonsteroidal androgen receptor modulator with tissue-selective activity in rats. It can bind to the rat AR with a Ki of 400nM and a...

ORM-15341
(CAS: 1297537-33-7)

ORM-15341, an androgen receptor antagonist, could have potential effect against prostate cancer and commonly found as an active main metabolite of ODM-201. IC50...

LGD-4033 (Ligandrol)
(CAS: 1165910-22-4)

LGD-4033, also known as VK5211 and Ligandrol, is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wast...

MI-136
(CAS: 1628316-74-4)

MI-136, with the potential to treat refractory prostate cancer, inhibits DHT-induced expression of androgen receptor (AR) target genes. In vitro: Treatment with...

LGD-2226
(CAS: 328947-93-9)

LGD-2226 is a selective androgen receptor modulator used in the treatment of muscle wasting and osteoporosis, shows to have an anabolic effect on muscle and bon...

ODM-201
(CAS: 1297538-32-9)

ODM-201 is a new-generation, potent and selective androgen receptor (AR) inhibitor which is potential useful for treatment of castration-resistant prostate canc...

Quick Inquiry

Verification code

Featured Items